Complaints and Returns at a Nutraceutical Contract Manufacturer: What QC Must Decide

At a nutraceutical contract manufacturer, a complaint and a return are two separate handoffs, and both are governed by 21 CFR Part 111 for US dietary supplement operations rather than by whatever the supplier's return policy says. A complaint is a record-and-review chain that ends with quality control approving what was decided and what was done. A return is a physical hold on material plus a quality-control disposition decision before anything goes back to saleable stock.

That rule text is captured in the eCFR on 2026-10-19. It describes what operations must do, not what any named manufacturer does. Treat it as the standard you hold a partner to, not a report card on one.

What a Returned Supplement Must Clear Before Restock

The rule is short, and it contains two gates rather than one. Returned dietary supplements must be identified and quarantined until quality control personnel conduct a material review and make a disposition decision. Gate one is physical: the goods are identified as returned and held apart from saleable stock. Gate two is a decision: QC reviews the material, then settles its fate — release, rework, reject or destroy.

Look at who is not in that sentence. The person answering the returns inbox, the account manager promising a replacement, the warehouse lead who needs the shelf space — none of them can close out a returned lot. The common mistake is treating a return as a shipping event: the pallet arrives, gets scanned in, and goes wherever there is room. The consequence is returned capsules sitting in the same picking aisle as new production, one inventory adjustment away from being shipped again. The fix is dull and it works: every returned unit gets marked as returned at intake and physically separated, so the picking process cannot see it while the material review is still open.

The Credit Memo Is Not a Disposition Decision

Most people assume that once a refund or a replacement is issued, the return is handled. In fact money and material run on different tracks. A credit memo is a commercial act about a customer's balance. A disposition decision is a quality act about material. Approving the first tells you nothing about the second.

The mistake is routing returns straight to customer service because that is where the complaint landed. One queue, one owner, one email thread — it feels efficient. The consequence arrives later, when someone asks what actually happened to those units. The credit note proves the customer was made whole. It says nothing about whether the goods were destroyed, reworked or put back into stock.

Build a returns intake step owned by QA. It assigns a hold status the day the goods land, and only a documented QC disposition clears it. The effect is that returned units cannot be picked against open orders, and the disposition record answers the question a customer will eventually ask about where the product went.

No return rate, refund window or supplier performance benchmark is set by §111.510, so resist quoting one to a supplier as if the rule established it.

A Logged Complaint Is Not a Reviewed Complaint

Quality control personnel must review and approve the decision about whether to investigate a product complaint, and must review and approve the findings and the follow-up action of any investigation performed. Nothing in that sentence is satisfied by closing a ticket.

A ticket gets opened. A reply goes out. The case gets filed. Three separate quality-control approvals are supposed to sit behind that sequence — whether to investigate at all, what the investigation found, and what was changed as a result — and an agent marking a ticket resolved supplies none of them.

Timestamps prove the email moved. They prove nothing about quality.

Measuring a supplier by complaint response time is easy to report and says almost nothing. The three approvals leave different evidence: a signed decision on whether to investigate, signed findings, and signed follow-up. Ask for those three signatures and the complaint file answers, without an email chain, what happened, what was found and what changed.

Most people assume a complaint portal with timestamps is the control. In fact the control is a signed quality-control review, and the portal is only where the paperwork starts.

Stop Investigating Only the Batch Named in the Complaint

§111.560(c) pushes the scope outward. The review and investigation by a qualified person, the quality-control review of whether to investigate, and the findings and follow-up action must extend to all relevant batches and records. Relevance sets the edge, not the lot number printed on the label.

The natural assumption is that a complaint concerns the one bottle a customer opened. Actually the record requirement reaches the batches around it — the ones sharing an input lot, a blend, a production window, a packaging run. A supplier that can only produce the single lot's paperwork has handed you half an answer.

A one-lot investigation looks complete, and it is usually the only file a supplier offers. The gap surfaces months later, when a retailer asks whether other lots are affected or a second customer reports the same off-note, and the trace starts from zero. Put the requirement in the quality agreement instead: the batch trace and the list of other lots reviewed belong attached to the complaint record, so the file already holds the answer.

What to Ask For When a Pallet Comes Back

Suppose a pallet of returned cases arrives at the contract manufacturer after a customer reports a taste problem. This is a walk-through, not a reported supplier case. Two documents separate a working handoff from a courtesy reply: a hold or quarantine record created the day the pallet landed, and a quality-control disposition entry naming the reviewer and the outcome. The same event should also leave a complaint file showing the investigation decision, the findings and the follow-up action.

Put these procurement questions in writing before the next order. Who physically segregates returns, and in what area? Who signs the disposition, by role? What must the complaint file contain before anyone may mark it closed? How does the supplier identify the other relevant lots for a given complaint? Each has a wrong answer that sounds fine on a call — "our QA handles it" — and a useful answer that names a role, a form and a location.

None of that verifies capability. A supplier can answer every question crisply and still fail an audit, and these sources say nothing about audit results, pricing, lead times, capacity or finished-product clinical efficacy. What you learn is whether the supplier can describe its own process precisely; only an audit or a records review during a visit tells you whether the description matches the floor.

What These Rules Do Not Tell You About a Supplier

The scope is narrow on purpose: US dietary supplement operations under 21 CFR Part 111, as captured in the eCFR up to 2026-10-19. Sections 111.510, 111.560(b) and 111.560(c) describe what operations must do. They say nothing about what a particular manufacturer does, and they are not a certification, a ranking or a compliance label for a pitch deck.

Tightening this has a real cost. A returns-and-complaints clause detailed enough to be useful takes negotiation time, and a supplier with a thin quality group may push back or slow onboarding while it builds forms it never needed. Keep the clause in proportion: it cannot substitute for a supplier audit, for finished-product testing data, or for standing in the warehouse and watching a returned pallet get stickered and moved. The paperwork requirement gets you a process you can inspect. It does not make the process good.

So do one thing before the next purchase order: ask for a blank returned-goods disposition form and one redacted complaint file with the quality-control approvals visible. If either is missing, list it as an open item in the quality agreement instead of assuming the process already runs.